Marico is amidst a copra deflationary cycle and plans to capitalize by building its futuristic portfolio. The co. is reinvesting its GM expansion into higher A&P spends to support new launches. In the recent past, the co. has launched several products in categories like premium hair oil, food and male grooming. Although the products are niche and may not have a high success rate, we admire the management's aggression which will aid in driving product diversification and long-term growth. Maricos 4Q performance was mixed albeit healthier vs. Dabur & GCPL. Revenues missed our estimates despite in-line volume growth while GM expansion beat estimates (tactical purchase of RM). We cut EPS estimates by 4-5% over FY20-21E to factor moderation in demand and GM expansion. However, we remain constructive on Marico and believe its performance will be superior to its peers in FY20. We value the co. at 35x on FY21 EPS arriving at a TP of Rs 386. Maintain BUY.